calendar
18,993 catalysts · 18,987 approval · 5,347 phase readout · 5,000 device 510k · 4,728 grant · 2,603 8k filing · 2,000 device pma
18,993 catalysts · 18,987 approval · 5,347 phase readout · 5,000 device 510k · 4,728 grant · 2,603 8k filing · 2,000 device pma
Sponsor: POWDER PHARMS. Form: SYSTEM. Route: INTRADERMAL
Sponsor: LILLY. Form: INJECTABLE. Route: INJECTION
Sponsor: JANSSEN PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ZYDUS PHARMS USA INC. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: GENUS. Form: SYRUP. Route: ORAL
Sponsor: ORION PHARMA. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: GLENMARK PHARMS LTD. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: XTTRIUM. Form: SOLUTION. Route: TOPICAL
Sponsor: DIFGEN PHARMS. Form: FILM, EXTENDED RELEASE. Route: TRANSDERMAL
Sponsor: SUN PHARM. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: ACTELION. Form: TABLET. Route: ORAL
Sponsor: ACTAVIS LABS FL INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: AUROBINDO PHARMA USA. Form: TABLET. Route: ORAL
Sponsor: TORRENT PHARMS. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: TARO PHARM INDS. Form: TABLET. Route: ORAL
Sponsor: ZYDUS PHARMS USA. Form: TABLET. Route: ORAL
Sponsor: SANDOZ. Form: INJECTABLE. Route: INJECTION
Sponsor: ORION PHARMA. Form: TABLET. Route: ORAL
Sponsor: BIONPHARMA. Form: CAPSULE, DELAYED RELEASE. Route: ORAL
Sponsor: HARROW EYE. Form: SUSPENSION/DROPS. Route: OPHTHALMIC
Sponsor: ACTELION. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: SCHERING. Form: SUSPENSION. Route: ORAL
Sponsor: ORGANON. Form: IMPLANT. Route: IMPLANTATION
Sponsor: SPECGX LLC. Form: TABLET. Route: ORAL
Sponsor: DORC. Form: SOLUTION. Route: OPHTHALMIC
Sponsor: XTTRIUM. Form: SOLUTION. Route: TOPICAL
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: HERITAGE PHARMA. Form: TABLET. Route: ORAL
Sponsor: KENVUE BRANDS. Form: SOLUTION. Route: ORAL
Sponsor: SANDOZ. Form: INJECTABLE. Route: INJECTION
Sponsor: QUAGEN. Form: TABLET. Route: ORAL
Sponsor: ABBVIE INC. Form: VIAL
Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL
Sponsor: STRIDES PHARMA INTL. Form: CAPSULE. Route: ORAL
Sponsor: LILLY. Form: INJECTABLE. Route: INJECTION
Sponsor: SANDOZ. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: KENVUE BRANDS. Form: SOLUTION. Route: ORAL
Sponsor: CHEPLAPHARM. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: CHEPLAPHARM. Form: TABLET. Route: ORAL
Sponsor: CHARTWELL RX. Form: SYRUP. Route: ORAL
Sponsor: SANDOZ. Form: EMULSION. Route: OPHTHALMIC
Sponsor: BAXTER HLTHCARE. Form: LIQUID. Route: INHALATION
Sponsor: CHARTWELL. Form: TABLET. Route: ORAL
Sponsor: TARO PHARM INDS. Form: TABLET. Route: ORAL
Sponsor: SUN PHARM INDS LTD. Form: TABLET. Route: ORAL
Sponsor: NATCO. Form: TABLET. Route: ORAL
Sponsor: GLENMARK PHARMS LTD. Form: TABLET. Route: ORAL